Skip to main content
FinSpry Logo
FinSpry
ACRS logo
ACRS
(NASDAQ)
Aclaris Therapeutics, Inc.
$4.20-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Aclaris Therapeutics (ACRS) Stock Price & Financial Analysis

Aclaris Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$4.01 - $4.22
52-Week High$4.89
52-Week Low$1.05
Open$4.05
Volume940.05K
Average Volume (3M)940.05K
Market Cap515.19M
Shares Outstanding122.66M
Price to Sales (P/S)64.89
Price to Book (P/B)4.93
EV/EBITDA-6.89
Revenue (TTM)7.83M
Net Income (TTM)-64.92M
Free Cash Flow (TTM)-47.99M
EPS (TTM)$-0.53
Profit Margin-829.58%
Operating Margin-951.64%
Return on Equity (ROE)-62.98%
Debt to Equity0.02
50-Day MA$3.52
200-Day MA$2.49
52-Week Change179.73%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Aclaris Therapeutics

What is the current stock price for ACRS?

As of the latest trading session, ACRS stock trades at $4.20. The 52-week range is $1.05–$4.89, with a day range of $4.01–$4.22.

What is the P/E ratio for ACRS?

The P/E ratio (Price-to-Earnings) for ACRS is shown in the Key Statistics section. This valuation metric helps compare Aclaris Therapeutics, Inc. to industry peers.

Does ACRS pay dividends?

Aclaris Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for ACRS?

Based on 2 analysts, the consensus for ACRS is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of ACRS?

Aclaris Therapeutics's market capitalization is $515.2M, classifying it as a small-cap company. Aclaris Therapeutics operates in the Healthcare sector within the Biotechnology industry.